1. Novel Anti-fibrotic Therapies
   Benita L. McVicker et al, 2017, Frontiers in Pharmacology CrossRef
2. Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease
   Jayne Louise Wilson et al, 2019, Frontiers in Immunology CrossRef
3. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
   Robert G Bennett et al, 2017, World Journal of Gastroenterology CrossRef
4. Targeting the Relaxin Pathway for Liver Disease Treatment
   Robert G. Bennett, 2018, EMJ Hepatology CrossRef